<SEC-DOCUMENT>0001437749-21-022232-index.html : 20210916
<SEC-HEADER>0001437749-21-022232.hdr.sgml : 20210916
<ACCEPTANCE-DATETIME>20210915214723
ACCESSION NUMBER:		0001437749-21-022232
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20210916
DATE AS OF CHANGE:		20210915

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Vaxart, Inc.
		CENTRAL INDEX KEY:			0000072444
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				591212264
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-239751
		FILM NUMBER:		211256842

	BUSINESS ADDRESS:	
		STREET 1:		170 HARBOR WAY, SUITE 300
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		(650) 550-3500

	MAIL ADDRESS:	
		STREET 1:		170 HARBOR WAY, SUITE 300
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Aviragen Therapeutics, Inc.
		DATE OF NAME CHANGE:	20160413

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Biota Pharmaceuticals, Inc.
		DATE OF NAME CHANGE:	20121113

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NABI BIOPHARMACEUTICALS
		DATE OF NAME CHANGE:	20100719
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>vxrt20210914b_424b5.htm
<TEXT>
Document 1 - file: vxrt20210914b_424b5.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>smlogo01.jpg
<TEXT>
Document 2 - file: smlogo01.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>vxrt20210914b_424b5img002.jpg
<TEXT>
Document 3 - file: vxrt20210914b_424b5img002.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>vxrt20210914b_424b5img003.jpg
<TEXT>
Document 4 - file: vxrt20210914b_424b5img003.jpg

</DOCUMENT>
</SEC-DOCUMENT>